CIK 0001287098
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
MAXCYTE, INC.
Sign in to watch- Ticker
- MXCT
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 522210438
- Phone
- +1 301-517-5556
- Business address
- 9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
- Former names
- MAXCYTE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-29 | Hemrajani Rekha Director | Grant or award · Stock Option (right to buy) | +26,900 | 26,900 | ||
| 2022-06-29 | Johnston John Joseph Director | Grant or award · Stock Option (right to buy) | +26,900 | 26,900 | ||
| 2022-06-29 | Mandell Art Director | Grant or award · Stock Option (right to buy) | +26,900 | 26,900 | ||
| 2022-04-11 | Sumen Cenk Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2022-03-25 | Masoud Maher EVP and General Counsel | Grant or award · Employee Stock Option (right to buy) | +242,000 | 242,000 | ||
| 2022-03-25 | Ross Thomas M. EVP, Global Sales & Marketing | Grant or award · Employee Stock Option (right to buy) | +142,000 | 142,000 | ||
| 2022-03-25 | Holtz Ron SVP and CAO | Grant or award · Employee Stock Option (right to buy) | +142,000 | 142,000 | ||
| 2022-03-25 | Murphy Amanda Louise Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +142,000 | 142,000 | ||
| 2022-03-25 | Doerfler Douglas President and CEO | Grant or award · Employee Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2021-11-22 | DOUGLAS RICHARD Director | Purchase | +20,000 | $11.12 | $222K | 20,000 |
| 2021-11-16 | Masoud Maher EVP and General Counsel | Exercise or conversion | +18,562 | $3.25 | $60K | 18,562 |
| 2021-11-16 | Masoud Maher EVP and General Counsel | Sale | −18,562 | $12.08 | $224K | 0 |
| 2021-11-16 | Masoud Maher EVP and General Counsel | Exercise or conversion · Employee Stock Option (right to buy) | −18,562 | 0 | ||
| 2021-11-16 | Murphy Amanda Louise Chief Financial Officer | Exercise or conversion | +37,306 | $4.42 | $165K | 37,306 |
| 2021-11-16 | Murphy Amanda Louise Chief Financial Officer | Sale | −37,306 | $12.08 | $451K | 0 |
| 2021-11-16 | Murphy Amanda Louise Chief Financial Officer | Exercise or conversion · Employee Stock Option (right to buy) | −37,306 | 1,000,000 | ||
| 2021-11-16 | Ross Thomas M. EVP, Global Sales | Exercise or conversion | +31,163 | $0.84 | $26K | 31,163 |
| 2021-11-16 | Ross Thomas M. EVP, Global Sales | Sale | −31,163 | $12.08 | $376K | 0 |
| 2021-11-16 | Ross Thomas M. EVP, Global Sales | Exercise or conversion · Employee Stock Option (right to buy) | −31,163 | 57,000 | ||
| 2021-11-16 | Holtz Ron SVP and CAO | Exercise or conversion | +39,130 | $0.04 | $2K | 164,381 |
Page 18 of 21 · 411 trades